| Literature DB >> 30968055 |
Derrick Nhan1, Eric J M Lentz2, Marilyn Steinberg3, Chaim M Bell1,3,4,5, Andrew M Morris1,3,4,5.
Abstract
BACKGROUND: To examine antibiotic stewardship program (ASP) structure among high-performing hospitals and determine which components of the 2016 Infectious Diseases Society of America (IDSA)/Society for Hospital Epidemiology of America (SHEA) ASP guidelines are implemented at each site.Entities:
Keywords: antibiotic resistance; antimicrobial stewardship; antimicrobial use
Year: 2019 PMID: 30968055 PMCID: PMC6451647 DOI: 10.1093/ofid/ofz104
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Survey Responses Relating to the Structure and Organization of Antimicrobial Stewardship Programs in Top-Ranking American Hospitalsa
| Does your institution have an active ASP? (n = 101) | No. of Respondents | % |
|---|---|---|
| Yes | 83 | 82 |
| No | 18 | 18 |
| How long has the ASP been active as of July 1st, 2016? (n = 80) | ||
| <1 y | 4 | 5 |
| 1–3 y | 14 | 18 |
| 3–5 y | 15 | 19 |
| >5 y | 47 | 59 |
| Who are the leaders of the ASP at your facility? (n = 78) | ||
| Physician and pharmacist co-leads | 46 | 59 |
| Physician | 27 | 35 |
| Pharmacist | 5 | 6 |
| Does your ASP fall within a program/department? (n = 80) | ||
| Yes | 58 | 73 |
| No | 22 | 28 |
| What hospital program or department does your ASP operate within? (n = 61) | ||
| Pharmacy | 35 | 58 |
| Both Infectious Disease and Pharmacy | 19 | 31 |
| Infectious Disease | 2 | 3 |
| Quality and Safety | 3 | 5 |
| Other | 2 | 3 |
| Does your ASP report to a committee or individual? (n = 80) | ||
| Committee | 68 | 85 |
| Individual | 8 | 10 |
| Neither | 4 | 5 |
| If your ASP reports to a committee, what committee does it report to? (n = 68) | ||
| Pharmacy and Therapeutics | 43 | 63 |
| Infection Disease/Control | 6 | 9 |
| Quality Control/Improvement | 4 | 6 |
| Medical Executive Committee | 2 | 3 |
| More than 1 of the above committees | 13 | 19 |
| If your ASP reports to an individual, what is their title? (n = 8) | ||
| Chief Medical Officer | 3 | 38 |
| Leader of Quality Affairs/Chief Quality Officer | 2 | 25 |
| Chief Nursing Officer | 1 | 13 |
| VP of Medical Affairs | 1 | 13 |
| Chief Safety Officer | 1 | 13 |
| Is there a budget dedicated solely to the ASP? (n = 80) | ||
| No | 42 | 53 |
| Yes | 38 | 48 |
| Under which program or department does the ASP budget fall? (n = 36) | ||
| Pharmacy | 22 | 61 |
| Infectious Disease | 1 | 3 |
| Health Care Quality | 2 | 6 |
| More than 1 of the above groups | 11 | 31 |
| In thousands of dollars, approximately how much is this budget annually? (n = 22) | ||
| <50 | 1 | 5 |
| 50–150 | 7 | 32 |
| 151–250 | 7 | 32 |
| 251–350 | 3 | 14 |
| 351–450 | 4 | 18 |
| What are the “other” roles in your ASP (other roles = roles besides physicians, pharmacists, nurses, information technologists, and epidemiologists)? (n = 35) | ||
| Microbiologist | 22 | 63 |
| Infection Prevention and Control | 10 | 29 |
| Other | 3 | 9 |
Abbreviation: ASP, antibiotic stewardship program.
aWhere the sample size, n, is less than expected (eg, for most questions, the eligible number of respondents was 83), it reflects that no response was provided.
Figure 1.Survey responses to questions about the staff and members of antimicrobial stewardship programs in top-ranking American hospitals. Each individual question asked how many full-time equivalents (FTEs) of each role the program had and gave each of the FTE ranges listed in the figure as answer options. Seventy-seven hospitals answered each question.
Survey Responses to Questions About Antimicrobial Stewardship Program Policies and Practices in Top-Ranking American Hospitals
| At your hospital, is the commitment to your ASP in the form of: (n = 79) | No. of Respondents | % |
|---|---|---|
| Salary support for ASP members | 71 | 90 |
| Ensuring participation from departments able to support the antimicrobial stewardship program | 67 | 85 |
| Support for training and education regarding antimicrobial stewardship | 63 | 80 |
| Allowing staff from relevant departments adequate time to participate in antimicrobial stewardship activities | 59 | 75 |
| A formal statement by the facility supporting efforts to improve antimicrobial usage | 57 | 72 |
| The inclusion of stewardship duties in job descriptions and performance reviews | 53 | 67 |
| Which of the following interventions to reduce inappropriate antimicrobial use does your ASP utilize? (n = 74) | ||
| Prospective audit and feedback of antimicrobial prescriptions for the prescriber | 65 | 88 |
| Facility-specific recommendations for specific infectious syndromes | 65 | 88 |
| Pre-authorization/formulary restrictions of antimicrobials | 61 | 82 |
| Antimicrobials restricted to ID physicians | 52 | 70 |
| Facility-specific recommendations for common infectious syndromes | 50 | 68 |
| Antimicrobial stewardship program intervention in cases with high risk of | 27 | 36 |
| Antimicrobial time-outs | 17 | 23 |
| Is there any system in place to monitor adherence to antimicrobial recommendations following feedback to the prescriber? (n = 74) | ||
| Yes | 57 | 77 |
| No | 17 | 23 |
| Which of the following antimicrobial optimization strategies does your ASP utilize? (n = 73) | ||
| Promoting the use of and transition toward oral antimicrobials over IV antimicrobials where appropriate | 68 | 93 |
| Strategies to minimize duration of antimicrobial therapy | 56 | 77 |
| Dedicated pharmacokinetic monitoring and adjustment program for patients on IV aminoglycosides | 50 | 68 |
| Documentation of dosing, duration, and indication for antimicrobials | 43 | 59 |
| Use of a computerized clinical decision support system when prescribing antimicrobials | 36 | 50 |
| Time-sensitive stop orders | 27 | 37 |
| Which of the following measurements of impact on antimicrobial use does your ASP utilize? (n = 73) | ||
| Days of therapy | 67 | 92 |
| Rate of | 65 | 89 |
| Measures of antimicrobial resistance | 55 | 75 |
| Defined daily doses | 55 | 75 |
| Use of key clinical outcomes for specific infectious syndromes | 9 | 12 |
| Which of the following measurements of impact on antimicrobial expenditure does your ASP utilize? (n = 67) | ||
| Purchasing data | 55 | 82 |
| Prescribing/administering costs | 27 | 40 |
| How often does your ASP report antimicrobial prescribing and resistance patterns to relevant staff? (n = 74) | ||
| Every 1–3 mo | 15 | 20 |
| Every 4–6 mo | 13 | 17 |
| Every 7–12 mo | 30 | 40 |
| Never | 13 | 17 |
| Other | 5 | 7 |
| Which of the following strategies (if any) does your ASP use to educate clinicians regarding resistance and optimal prescribing habits? (n = 69) | ||
| Didactic lectures/presentations | 61 | 88 |
| Web-based educational resources | 30 | 43 |
| Education pamphlets | 13 | 19 |
| Posters/flyers | 13 | 19 |
| Reviewing de-identified cases with providers | 8 | 12 |
| Other | 8 | 12 |
| None | 1 | 1 |
Abbreviations: ASP, antibiotic stewardship program; ID, infectious disease; IV, intravenous.